Picture of Crown LiquidationCo NV in liquidatie logo

CNTGF Crown LiquidationCo NV in liquidatie News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro Cap

Brief: Centogene Sets Mission To Enable The Cure Of 100 Rare Diseases Within The Next 10 Years

June 22 (Reuters) - Centogene NV  39K.MU :
    * CENTOGENE SETS MISSION TO ENABLE THE CURE OF 100 RARE
DISEASES
WITHIN THE NEXT 10 YEARS
    * CENTOGENE NV - CLEAR PRIORITIES SET FOR THERAPEUTIC
DISEASE
AREAS, FOCUSING ON RARE NEUROLOGICAL (CNS) AND METABOLIC
DISORDERS
    * CENTOGENE NV - MID-TERM TARGETS SET TO REACH 1 MILLION
PATIENTS
IN BIO/DATABANK AND 10 FULL DISEASE MODELS FOR RARE DISEASE
RESEARCH AND DEVELOPMENT PARTNERING

Source text for Eikon:  ID:nGNX1hb6kq 
Further company coverage:  39K.MU 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Crown LiquidationCo NV in liquidatie

See all news